WHWK
Whitehawk Therapeutics, Inc.
NASDAQ: WHWK · HEALTHCARE · BIOTECHNOLOGY
$4.04
-2.18% today
Updated 2026-04-29
Market cap
$194.92M
P/E ratio
—
P/S ratio
27.28x
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Whitehawk Therapeutics, Inc. (WHWK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $16.66M | $18.82M | $157.91M | $184.24M | $132.42M | $70.32M |
| Cash & equivalents | $15.96M | $4.46M | $148.99M | $39.02M | $62.89M | $28.67M |
| Current assets | $16.31M | $18.68M | $151.27M | $180.03M | $124.59M | $61.29M |
| Total liabilities | $25.75M | $31.26M | $21.50M | $25.86M | $27.23M | $17.84M |
| Current liabilities | $25.62M | $30.06M | $15.27M | $18.84M | $26.39M | $17.07M |
| Long-term debt | — | $1.10M | — | — | — | — |
| Shareholder equity | $-9.09M | $-12.43M | $136.41M | $158.38M | $105.19M | $52.48M |
| Retained earnings | $-29.12M | $-32.59M | $-142.69M | $-203.20M | $-268.96M | $-332.65M |
| Accounts receivable | $284896.00 | $14.15M | $0.00 | $1.86M | $5.49M | $5.90M |
| Inventory | — | — | $0.00 | $1.86M | $6.43M | $5.31M |
| Goodwill | — | — | — | — | — | — |